Gregory S. Moss - 05 Nov 2025 Form 3 Insider Report for Evommune, Inc.

Role: Chief Business & Legal Officer
Signature: /s/ Gregory S. Moss
Issuer symbol: EVMN on NYSE
Transactions as of: 05 Nov 2025
Net transactions value: $0
Form type: 3
Filing time: 05 Nov 2025, 20:08:23 UTC
Previous filing: 10 Jun 2025
Next filing: 12 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Moss Gregory S.	Chief Business & Legal Officer	C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO	/s/ Gregory S. Moss	05 Nov 2025	0001742496

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EVMN	Common Stock						74,459	05 Nov 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EVMN	Series B Preferred Stock							05 Nov 2025	Common Stock	3,175		By Trust	F2, F3
holding	EVMN	Employee Stock Option (Right to Buy)							05 Nov 2025	Common Stock	133,834	$3.07	Direct	F4
holding	EVMN	Employee Stock Option (Right to Buy)							05 Nov 2025	Common Stock	35,323	$3.58	Direct	F5
holding	EVMN	Employee Stock Option (Right to Buy)							05 Nov 2025	Common Stock	65,318	$3.84	Direct	F6
holding	EVMN	Employee Stock Option (Right to Buy)							05 Nov 2025	Common Stock	8,090	$1.71	Direct	F7
holding	EVMN	Employee Stock Option (Right to Buy)							05 Nov 2025	Common Stock	62,068	$1.71	Direct	F8
holding	EVMN	Employee Stock Option (Right to Buy)							05 Nov 2025	Common Stock	114,552	$2.99	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. One fourth (1/4) of the RSUs shall vest on each of December 9, 2025, December 9, 2026, December 9, 2027 and December 9, 2028, subject to the Reporting Person's continuous service through each such vesting date.
F2	The Series B Preferred Stock is convertible into Common Stock on a 1-for-7.8721 basis and has no expiration date. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock will be converted into shares of Common Stock of the Issuer.
F3	The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.
F4	One fourth (1/4) of the shares subject to the option award vested on June 27, 2023 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F5	One fourth (1/4) of the shares subject to the option award vested on January 13, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F6	One fourth (1/4) of the shares subject to the option award vested on May 12, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F7	One fourth (1/4) of the shares subject to the option award vested on January 6, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F8	One fourth (1/4) of the shares subject to the option award vested on March 22, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F9	One fourth (1/4) of the shares subject to the option award shall vest on December 9, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.